Key Commercialisation Milestnoes achieved and in progress - 2011
* Completed 30 patient heart patch trial (safety & efficacy) Q2,2009
* NAMSA biocompatibility testing for regulatory listing ~ completed ~ Q2,2010
* Regulatory conformity assessment application completed ~ Q4.2010
* Global Heart Valve ADAPT Sterilisation phase completed ~ Q4.2010
* Australian TGA, and European CE regulatory applications filed ~ Q1,2011
* FDA application to follow TGA/CE ~ Q2, 2011
* Global Heart Valve Project Completed ~ Q2,2011
* Commercial product Cardiocel ready for AUST & ASIAN markets ~ Q2,2011
* Cardiocel patch distribution agreement for Europe ~ Q3.2011~~~~~~~
Feasibility study plan continuing with a global heart valve company
Commercialisation partnerships being explored for specialty products, e.g. percutaneous tissue heart valves
R&D continuing for emerging growth opportunities utilizing the ADAPT biomaterial mesh for the growth of stem cells, chrondocytes (cartilage) and keratinocytes (skin)~~~~~~~
129 mil shares (fully paid ordinary)
Tight reg - 76% held by top 50
Low cash burn - 100k per month (re: 4th Qtr 4C)
Cash position - 750k (31/12/10)~~~~~~~
My target - 10c by 30/04/11
Key Commercialisation Milestnoes achieved and in progress - 2011...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.256M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| BOD (ASX) Chart |
Day chart unavailable